Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2022 14:30 ET | Source: Bon Secours Liver Institute of Richmond

Bon Secours Liver Institute of Richmond Participating in RESPONSE, a Global Phase 3 Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC)

Novel oral medication could provide a new treatment option for people with PBC who have not achieved the recommended treatment goal or who cannot tolerate first-line therapy that prevents them from...